Stopping a medication?
Time for a medication check-up?
Risk factors for MCI and dementia
Handling tough decisions as a caregiver
Cholesterol's various forms
Are you at risk for high blood pressure?
How to fall without injury
How high blood pressure harms your health
How we make memories
Treating mild cognitive impairment
Adam S. Cheifetz, MD
Contributor
Dr. Adam Cheifetz is director of the center for inflammatory bowel disease and medical director of infusion services at Beth Israel Deaconess Medical Center, and professor of medicine at Harvard Medical School. He is a well-recognized leader in the treatment of Crohn’s disease, ulcerative colitis, and other inflammatory bowel diseases. He is involved in multiple research projects relating to IBD, and has published over 200 articles and chapters on the subject.
His research currently focuses on therapeutic drug monitoring and optimizing the use of biologics through the proactive use of drug concentrations and antibodies, and he has published extensively in this area. Dr. Cheifetz was the first to demonstrate that proactive monitoring of infliximab and adalimumab concentrations and dosing to a therapeutic window improves outcomes when compared to standard of care.
Stopping a medication?
Time for a medication check-up?
Risk factors for MCI and dementia
Handling tough decisions as a caregiver
Cholesterol's various forms
Are you at risk for high blood pressure?
How to fall without injury
How high blood pressure harms your health
How we make memories
Treating mild cognitive impairment
